Media Summary: This video highlights application of pluripotent stem cells for Speakers: Roberto Iacone, PhD., Pharma and Research Development (pRED) Hoffmann - LaRoche Bradd Swanson, PhD, Senior ... Stefan Janssens, MD, PhD, University Hospital Leuven, Leuven, Belgium, describes the evolving landscape of regenerative ...
Ipscs For Cardiovascular Diseases - Detailed Analysis & Overview
This video highlights application of pluripotent stem cells for Speakers: Roberto Iacone, PhD., Pharma and Research Development (pRED) Hoffmann - LaRoche Bradd Swanson, PhD, Senior ... Stefan Janssens, MD, PhD, University Hospital Leuven, Leuven, Belgium, describes the evolving landscape of regenerative ... 04:02 - Cardiac Stem Cells: A Patient Perspective - Pat Farrant, 12:34 - Cellular Reprogramming Approaches for The development of this video was funded under NIE Incentivsing ICT Use Innovation Grant to Asst. Prof. Chen Zhong (I3G 02/16 ... Human pluripotent stem cells in understanding genetic
Mark Mercola, PhD Stanford University Recorded on 09/14/2020. [Show ID: 36334] Please Note: Knowledge about health and ... ... to develop personalised treatments for Applications of Stem Cell Biobanks: Prof. Dr. Christine Mummery (Leiden University Medical Center, NL) gives an overview on ... In a proof-of-concept study, Mayo Clinic investigators have demonstrated that induced pluripotent stem (iPS) cells can be used to ... Professor Taylor speaking as part of the Young Pharmacologist's symposium. Stem cells: pharmacology and therapeutics. Left Ventricular Hypertrophy (LVH) is one of the most potent risk factors for
Timothy J. Kamp, MD, PhD, describes the outcomes from clinical Left ventricular hypertrophy (LVH) is a common, complex, and independent risk factor for
